Relay Therapeutics

Recent Finacing

Series C

Recent Raise

$400M

Relay Therapeutics is a drug discovery company that operates an integrated platform combining structural biology, biophysics, computational simulation, chemistry and biology to analyze protein motion and design oncology-focused therapeutics.

Founded 2016

Massachusetts, United States

251-500

Publicly Traded

relaytx.com

Highlights

Focus Areas

Biotechnology

Health Care

Therapeutics

Recent Investors

Financials

$520M

Total Raised

3

Funding rounds

12

Investors

Team

Upgrade to view the team

See the team members at Relay Therapeutics.